View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
John Kastelein is a renowned expert in lipoprotein metabolism and atherosclerotic cardiovascular disease (ASCVD) research. In this discussion, John delves deep into familial hypercholesterolemia (FH), a genetic disorder characterized by high levels of LDL cholesterol in the blood that increases the risk of developing heart disease. He covers its definition, genetic underpinnings, and clinical identification. He then explores the therapeutic options available for the prevention and treatment of cardiovascular disease, including the captivating history of CETP inhibitors. He explains the past shortcomings of previous CETP inhibitors before underscoring the compelling potential of the latest iterations, not only for cardiovascular disease but also for conditions like Alzheimer's disease and type 2 diabetes. Moreover, he unveils the intricate role of APOE, shedding light on why the APOE4 isoform codes for a protein that significantly increases the risk of Alzheimer's disease and cardiovascular disease. Concluding the discussion, John shares a profound sense of optimism, envisioning the possibility of targeted therapeutic interventions for high-risk patients in the near future.
We discuss:
Connect With Peter on Twitter, Instagram, Facebook and YouTube
A masterclass on insulin resistance—mechanisms and implications | Gerald Shulman, M.D., Ph.D. (#140 rebroadcast)
#231 - AMA #41: Medicine 3.0, developments in the field of aging, healthy habits in times of stress, and more
#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D.
#229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
#228 ‒ Improving body composition, female-specific training principles, and overcoming an eating disorder | Holly Baxter, APD
#227 - AMA #40: Body composition, protein, time-restricted feeding, fasting, DEXA scans, and more
#226 ‒ The science of happiness | Arthur Brooks, Ph.D.
#225 ‒ The comfort crisis, doing hard things, rucking, and more | Michael Easter, MA
#224 ‒ Dietary protein: amount needed, ideal timing, quality, and more | Don Layman, Ph.D.
#223 - AMA #39: The Centenarian Decathlon, zone 2, VO2 max, and more
#222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D
#221 ‒ Understanding sleep and how to improve it
#220 ‒ Ketamine: Benefits, risks, and promising therapeutic potential | Celia Morgan, Ph.D.
#219 ‒ Dialectical behavior therapy (DBT): skills for overcoming depression , emotional dysregulation, and more | Shireen Rizvi, Ph.D., ABPP
#218 - AMA #38: Can you exercise too much?
#217 ‒ Exercise, VO2 max, and longevity | Mike Joyner, M.D.
#216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
#215 - The gut-brain connection | Michael Gershon, M.D.
#214 - AMA #37: Bone health—everything you need to know
#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Huberman Lab
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.